Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Chronic pain in focus for CombiGene's new collaboration

Lärkberget

CombiGene has entered into a collaboration agreement with Danish Zyneyro regarding the continued development of treatments for chronic pain conditions - a peptide with short-term benefits and a gene therapy with potentially lifelong effects. To find out more about what sparked CombiGene's interest in Zyneyro and their projects in temporary and chronic pain conditions, BioStock contacted CombiGene's CEO Jan Nilsson.

Read the full interview with CombiGene's CEO Jan Nilsson at biostock.se:

https://www.biostock.se/en/2023/01/chronic-pain-in-focus-for-combigenes-new-collaboration/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.